ELIXIR - an intergovernmental research infrastructure provider for bio and health data - celebrated its 5th anniversary in Brussels. They invited Professor Rothe to chair a panel session about Value creation with bio data. He was accompanied by founders and managers from large corporations: Liz Reynolds (GENERAL BIOINFORMATICS LIMITED) , Catherine Sirven (Bayer Crop Science), Filip Pattyn (ONTOFORCE), and Herman van Vlijmen (The Janssen Pharmaceutical Companies of Johnson & Johnson).
News vom 13.12.2018
The discussion covered a lot of ground: from the value of #biodata (somewhere between "gold", sometimes "overly expensive" to somehow "free") over FAIRness of proprietary data to the requirements of public data (e.g., service quality and sustainability) without which not even large corporates would be able to work properly. FAIR refers to four principles for research infrastructures that become more important for the private sector as well: findable, accessible, interoperable, and reusable.